ADAGE CAPITAL PARTNERS GP, L.L.C. - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 145 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$17,655,800
-17.6%
860,000
-4.4%
0.03%
-17.5%
Q1 2024$21,420,000
+10.1%
900,0000.0%0.04%0.0%
Q4 2023$19,449,000
+33.9%
900,000
-10.0%
0.04%
+21.2%
Q3 2023$14,520,000
-25.0%
1,000,000
+8.1%
0.03%
-21.4%
Q2 2023$19,360,250
+16.0%
925,000
+17.1%
0.04%
+13.5%
Q1 2023$16,684,800
-30.3%
790,000
-16.0%
0.04%
-35.1%
Q4 2022$23,923,000
-20.4%
940,000
-24.8%
0.06%
-23.0%
Q3 2022$30,038,000
+26.2%
1,250,000
+1.0%
0.07%
+34.5%
Q2 2022$23,806,000
+27.0%
1,237,300
+14.7%
0.06%
+52.8%
Q1 2022$18,747,000
-28.6%
1,078,641
-10.1%
0.04%
-23.4%
Q4 2021$26,268,000
-52.0%
1,200,000
-58.1%
0.05%
-56.5%
Q3 2021$54,774,000
+28.1%
2,866,272
+15.1%
0.11%
+28.6%
Q2 2021$42,775,000
+9.3%
2,491,272
+42.4%
0.08%
+5.0%
Q1 2021$39,130,000
-3.9%
1,750,000
-4.4%
0.08%
-10.1%
Q4 2020$40,709,000
+62.2%
1,830,439
+7.7%
0.09%
+41.3%
Q3 2020$25,092,000
+61.2%
1,700,000
+61.9%
0.06%
+57.5%
Q2 2020$15,561,000
+41.9%
1,050,000
+5.0%
0.04%
+21.2%
Q1 2020$10,970,000
-0.0%
1,000,000
-20.0%
0.03%
+22.2%
Q4 2019$10,975,000
+17.5%
1,250,0000.0%0.03%
+17.4%
Q3 2019$9,338,000
-32.0%
1,250,000
-15.3%
0.02%
-32.4%
Q2 2019$13,732,000
+68.7%
1,475,000
-4.8%
0.03%
+70.0%
Q1 2019$8,138,0001,550,0000.02%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,025,000$19,588,0003.91%
Ghost Tree Capital, LLC 575,000$10,988,0003.21%
Avidity Partners Management LP 4,823,400$92,175,0002.04%
BVF INC/IL 2,486,429$47,516,0001.85%
FRAZIER MANAGEMENT LLC 1,188,135$22,705,0001.82%
Nantahala Capital Management 2,657,159$50,778,0001.60%
Boxer Capital, LLC 2,287,782$43,720,0001.53%
ACUTA CAPITAL PARTNERS, LLC 206,126$3,939,0001.39%
SPHERA FUNDS MANAGEMENT LTD. 750,603$14,344,0001.20%
PFM Health Sciences, LP 1,856,738$35,482,0001.04%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders